Unimedic Pharma AB out-license Melatonin oral solution in Belgium to TwinPharma BV

Unimedic Pharma AB has signed a distribution agreement with TwinPharma BV for the launch of Melatonin 1 mg/ml oral solution in Belgium.

Unimedic Pharma and TwinPharma entered into a supply and distribution agreement in 2017 and the addition of Melatonin 1mg/ml is the third product in the collaboration.

In this partnership, TwinPharma is appointed exclusive distributor of Melatonin Unimedic Pharma and carry the responsibility for marketing, distribution, and sales in Belgium, while Unimedic Pharma is responsible for the manufacturing and delivery of the product.

Johan Frödin, CEO of Unimedic Pharma says “We are truly happy to add another product to our close partnership with TwinPharma who has proven themselves as a local champion with a solid track record of marketing and sales of pharmaceuticals. Our product will soon be available for treatment of insomnia in children and adolescents with ADHD in Belgium.”

Gert van Alewijk, Managing Partner of TwinPharma, says “We are honored to once again be appointed the exclusive distributor of Unimedic Pharma which is an innovative and reliable partner that is crucial for our success. Melatonin oral solution will fulfill the existing need for patients and the prescribers for a tailormade treatment.”

About Melatonin Unimedic Pharma 1 mg/ml oral solution

Melatonin oral solution contains the active substance melatonin, which is a hormone produced naturally by the body. The hormone helps regulate the body’s day and night rhythm. Melatonin Unimedic Pharma is approved for insomnia in children and adolescents (6-17 years of age) with attention deficit hyperactivity disorder (ADHD) where healthy sleeping routines has not worked well enough, and for short-term treatment of jet lag in adults.

About Unimedic Pharma AB

Unimedic Pharma is a fully integrated Swedish specialty pharma company with broad experience in drug development, distribution, and marketing of pharmaceuticals. Unimedic Pharma supply the Nordic region and northern Europe with a wide range of pharmaceuticals in several therapeutic areas. The company’s core purpose is to contribute to better health. By developing niche pharmaceuticals for children and adults with special medical needs in close collaboration with the healthcare sector, we strive to reach our mission.

About TwinPharma BV

TwinPharma is successful in sales and marketing of specialized pharmaceuticals in Belgium. TwinPharma is well respected and trusted company and will do it outmost best to service the children with ADHD and sleeping problems in Belgium and adults with short-term treatment of jet lag.

TwinPharma is active in the Netherlands, Belgium, and Luxembourg (www.twinpharma.com). It is also part of the Your Pharma Partner in Europe alliance.